SCHEMBL13367153

SCHEMBL13367153

CC(C)(C)C(=O)OCCF

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PRKCA P17252 1/20 0.41
CYP4F2 P78329 2/20 0.35
CYP4A11 Q02928 2/20 0.35
ELANE P08246 3/20 0.32
MEN1 O00255 1/20 0.31
GBA1 P04062 1/20 0.31
MAPT P10636 1/20 0.31
RECQL P46063 1/20 0.31
KMT2A Q03164 1/20 0.31
NPC1 O15118 1/20 0.31
CASP3 P42574 1/20 0.31
RAB9A P51151 1/20 0.31
SENP8 Q96LD8 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
BTN3A1 O00481 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19742334 0.86 POLB (0.41) POLBGAANPSR1PRKCACYP4F2
SCHEMBL4258156 0.84 POLB (0.48) POLBGAANPSR1PRKCACYP4F2
SCHEMBL19857456 0.83 CYP4F2 (0.31) POLBGAANPSR1CYP4F2CYP4A11
SCHEMBL150006 0.82 PRKCA (0.47) POLBGAANPSR1PRKCACYP4F2
SCHEMBL19448898 0.82 POLB (0.33) POLBGAANPSR1PRKCA
Ammonia Solution, Strong SCHEMBL27804637 0.80 PRKCA (0.45) POLBGAANPSR1PRKCACYP4F2
SCHEMBL7096949 0.80 POLB (0.43) POLBGAANPSR1PRKCACYP4F2
SCHEMBL2610375 0.79 CYP4F2 (0.40) CYP4F2CYP4A11
SCHEMBL18373345 0.79 CYP4F2 (0.33) CYP4F2CYP4A11
SCHEMBL7989588 0.79 POLB (0.46) POLBGAANPSR1PRKCACYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170373348-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND ENERGY STORAGE DEVICE USING THE SAME UBE INDUSTRIES, LTD (JP) 2017-12-28 US claimed
US-12032290-B2 Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for manufacturing electronic device FUJIFILM CORPORATION (JP) 2024-07-09 US disclosed
US-11802105-B2 Treprostinil derivatives and compositions and uses thereof Corsair Pharma, Inc. (US) 2023-10-31 US disclosed
US-11639364-B2 Potent sialyltransferase inhibitors STICHTING RADBOUD UNIVERSITEIT (NL) 2023-05-02 US disclosed
US-11639364-B2 Potent sialyltransferase inhibitors STICHTING RADBOUD UNIVERSITEIT (NL) 2023-05-02 US disclosed
US-20230015308-A1 SUBSTITUTED THIAZOLE AROMATIC RING-BASED COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) 2023-01-19 US disclosed
US-20210107931-A1 New potent sialyltransferase inhibitors STICHTING KATHOLIEKE UNIVERSITEIT (NL) 2021-04-15 US disclosed
US-20180170855-A1 TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF Corsair Pharma, Inc. 2018-06-21 US disclosed
US-9957220-B2 Treprostinil derivatives and compositions and uses thereof Corsair Pharma, Inc. (US) 2018-05-01 US disclosed
US-9873709-B2 Triazolopyridine compounds, compositions and methods of use thereof GENENTECH, INC. (US) 2018-01-23 US disclosed
US-20170226132-A1 TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2017-08-10 US disclosed
US-20170114246-A1 BLOCK COPOLYMERS FOR DIRECTED SELF-ASSEMBLY APPLICATIONS ELPIS TECHNOLOGIES INC. (CA) 2017-04-27 US disclosed
US-9394227-B1 Treprostinil derivatives and compositions and uses thereof Corsair Pharma, Inc. (US) 2016-07-19 US disclosed
US-8895583-B2 Soluble guanylate cyclase activators MERCK SHARP & DOHME CORP. (US) 2014-11-25 US disclosed
US-20140057895-A1 INDAZOLE- AND PYRROLOPYRIDINE-DERIVATIVE AND PHARMACEUTICAL USE THEREOF SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-02-27 US disclosed
US-20130210798-A1 SOLUBLE GUANYLATE CYCLASE ACTIVATORS MERCK SHARP & DOHME LLC 2013-08-15 US disclosed
CN-102186890-B Fluorine-containing sulfonates having polymerizable anions and manufacturing method therefor, fluorine-containing resins, resist compositions, and pattern-forming method using same CENTRAL GLASS CO LTD 2013-07-31 CN disclosed
CN-102186890-A Fluorine-containing sulfonates having polymerizable anions and manufacturing method therefor, fluorine-containing resins, resist compositions, and pattern-forming method using same CENTRAL GLASS CO LTD 2011-09-14 CN disclosed
US-7446110-B2 17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators MERCK & CO., INC. (US) 2008-11-04 US disclosed
US-20070054933-A1 17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators MERCK & CO., INC (US) 2007-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210107931-A1 New potent sialyltransferase inhibitors NMT1, NEU1, NMT2 POLB 4315/4885GAA 447/4885NPSR1 1483/4885
US-20130210798-A1 SOLUBLE GUANYLATE CYCLASE ACTIVATORS GUCY1B1, GUCY1A1, GUCY1A2 POLB 3659/4885GAA 990/4885NPSR1 2566/4885
US-11802105-B2 Treprostinil derivatives and compositions and uses thereof PTGIS, PTGIR, PDE3A POLB 758/4885GAA 1269/4885NPSR1 1252/4885
US-20180170855-A1 TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF PTGIS, PTGIR, PDE3A POLB 758/4885GAA 1269/4885NPSR1 1252/4885
US-20230015308-A1 SUBSTITUTED THIAZOLE AROMATIC RING-BASED COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF WEE1, CBR3, GLRX3 POLB 3913/4885GAA 2047/4885NPSR1 2879/4885
US-20140057895-A1 INDAZOLE- AND PYRROLOPYRIDINE-DERIVATIVE AND PHARMACEUTICAL USE THEREOF HTR4, HTR3B, HTR3A POLB 2810/4885GAA 3565/4885NPSR1 67/4885
US-20070054933-A1 17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators AR, SHBG, NR5A1 POLB 1817/4885GAA 2605/4885NPSR1 1751/4885
US-20170226132-A1 TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF ABL1, JAK2, JAK1 POLB 2553/4885GAA 3271/4885NPSR1 1871/4885
US-11639364-B2 Potent sialyltransferase inhibitors NEU1, NMT1, NEU2 POLB 4243/4885GAA 412/4885NPSR1 1144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.